![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 5, 3295-3301, February 2, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
, and
§**
From the In order to understand the mechanism for
insoluble neurotoxic protein polymerization in Alzheimer's disease
(AD) brain neurons, we examined protein and gene expression for
transglutaminase (TGase 2; tissue transglutaminase (tTG)) in
hippocampus and isocortex. We found co-localization of tTG protein and
activity with tau-positive neurofibrillary tangles, whereas mRNA
and sequence analysis indicated an absolute increase in tTG
synthesized. Although apoptosis in AD hippocampus is now an established
mode of neuronal cell death, no definite underlying mechanism(s) is
known. Since TGase-mediated protein aggregation is implicated in
polyglutamine ((CAG)n/Qn expansion) disorder apoptosis,
and expanded Qn repeats are excellent TGase substrates, a role
for TGase in AD is possible. However, despite such suggestions almost
20 years ago, the molecular mechanism remained elusive. We now present
one possible molecular mechanism for tTG-mediated, neurotoxic protein
polymerization leading to neuronal apoptosis in AD that involves not
its substrates (like Qn repeats) but rather the unique presence
of alternative transcripts of tTG mRNA. In addition to a
full-length (L) isoform in aged non-demented brains, we found a short
isoform (S) lacking a binding domain in all AD brains. Our current
results identify intron-exon "switching" between L and S isoforms,
implicating G-protein-coupled signaling pathways associated with tTG
that may help to determine the dual roles of this enzyme in neuronal life and death processes.
Neurobiology Research Lab, Heartland
Veterans Integrated Service Network, Kansas City, Missouri 64128, the § Departments of Neurology, ¶ Pathology and
Laboratory Medicine, and ** Pharmacology, Toxicology, and Therapeutics,
the University of Kansas Medical Center,
Kansas City, Kansas 66160, and
Department of
Integrative Biology, Pharmacology, and Physiology, University of Texas,
Houston Health Science Center, Houston, Texas 77225

To whom correspondence should be addressed: Neurobiology
Research Lab (151), Heartland Veterans Health Service Network, Veterans Affairs Medical Center, 4801 Linwood Blvd., Kansas City, MO 64128. Tel.: 816-861-4700 (ext. 7079); Fax: 816-922-3375; E-mail:
serpin@eagle.cc.ukans.edu.
This article has been cited by other articles:
![]() |
T.-S. Lai, Y. Liu, W. Li, and C. S. Greenberg Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells FASEB J, December 1, 2007; 21(14): 4131 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, Y.-S. Kim, D.-H. Choi, M. S. Bang, T. R. Han, T. H. Joh, and S.-Y. Kim Transglutaminase 2 Induces Nuclear Factor-{kappa}B Activation via a Novel Pathway in BV-2 Microglia J. Biol. Chem., December 17, 2004; 279(51): 53725 - 53735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Junn, R. D. Ronchetti, M. M. Quezado, S.-Y. Kim, and M. M. Mouradian Tissue transglutaminase-induced aggregation of alpha -synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies PNAS, February 18, 2003; 100(4): 2047 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruoppolo, S. Orru, S. Francese, I. Caputo, and C. Esposito Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats Protein Sci., January 1, 2003; 12(1): 170 - 179. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |